These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1481797)

  • 1. Triazolam use in a university medical center.
    Schwinghammer TL; Young BG; Hirsh JD
    Am J Hosp Pharm; 1992 Dec; 49(12):2939-43. PubMed ID: 1481797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients.
    Calderón-Ospina C; Bustamante-Rojas C
    Int J Pharm Pract; 2010 Aug; 18(4):230-5. PubMed ID: 20636675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions in an elderly outpatient population.
    Schneider JK; Mion LC; Frengley JD
    Am J Hosp Pharm; 1992 Jan; 49(1):90-6. PubMed ID: 1570873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal.
    Mallik S; Palaian S; Ojha P; Mishra P
    Pak J Pharm Sci; 2007 Jul; 20(3):214-8. PubMed ID: 17545106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions.
    Seifert CF; Kennedy S
    Pharmacotherapy; 2004 Jun; 24(6):776-83. PubMed ID: 15222668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.
    Nguyen JK; Fouts MM; Kotabe SE; Lo E
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):36-41. PubMed ID: 16730619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of hospital admissions associated with digitalis glycosides].
    Schmiedl S; Szymanski J; Rottenkolber M; Drewelow B; Haase G; Hippius M; Reimann IR; Siegmund W; May K; Haack S; Hasford J; Thürmann PA;
    Med Klin (Munich); 2007 Aug; 102(8):603-11. PubMed ID: 17694280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance through adverse drug reaction reporting: improving hypnotic prescribing.
    Phillips MS
    Hosp Pharm; 1990 Mar; 25(3):246-8. PubMed ID: 10170509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System.
    Wysowski DK; Barash D
    Arch Intern Med; 1991 Oct; 151(10):2003-8. PubMed ID: 1929688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of adverse drug reactions in a dermatology department.
    Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].
    Ciorciaro C; Hartmann K; Kuhn M
    Schweiz Med Wochenschr; 1998 Feb; 128(7):254-8. PubMed ID: 9540150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of adverse drug reactions in adult medical inpatients.
    Bowman L; Carlstedt BC; Black CD
    Can J Hosp Pharm; 1994 Oct; 47(5):209-16. PubMed ID: 10172139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a hospital-based target drug program on institutional and community prescribing behavior.
    Taketomo RT; Andersen RC; Sherwood CL; Findley CI
    Am J Hosp Pharm; 1989 Sep; 46(9):1784-6. PubMed ID: 2801711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug related hospital admissions in subspecialities of internal medicine.
    Hallas J
    Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic risk-assessment model for identifying patients with adverse drug reactions.
    Tschepik W; Segal R; Sherrin TP; Schneider DN; Hammond RL
    Am J Hosp Pharm; 1990 Feb; 47(2):330-4. PubMed ID: 2309721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of patient age and physician training on choice and dose of benzodiazepine hypnotic drugs.
    Shorr RI; Bauwens SF
    Arch Intern Med; 1990 Feb; 150(2):293-5. PubMed ID: 2302005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions in hospitalized children in Fortaleza, Brazil.
    dos Santos DB; Coelho HL
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):635-40. PubMed ID: 16287200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.